Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Did you mean camphor natural and cannabidiolic and levomenthol?
Displaying drugs 13626 - 13650 of 14855 in total

Propyphenazone

Experimental

Vactosertib

Vactosertib is under investigation in clinical trial NCT03724851 (Vactosertib in Combination With Pembrolizumab in Metastatic Colorectal or Gastric Cancer).
Investigational

N'-[4-(2,4-Dimethyl-1,3-thiazol-5-yl)-2-pyrimidinyl]-N-hydroxyimidoformamide

Experimental

CRA_23653

Experimental

4-[(4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE

Experimental

(4-fluorophenyl)(pyridin-4-yl)methanone

Experimental

3-({[(1Z)-(2-methoxyphenyl)methylidene]amino}oxy)propanoic acid

Experimental

6-amino-2-methyl-1,7-dihydro-8H-imidazo[4,5-g]quinazolin-8-one

Experimental

6-(2-fluorophenyl)-N-(pyridin-3-ylmethyl)imidazo[1,2-a]pyrazin-8-amine

Experimental

1-[(2S)-4-(5-BROMO-1H-PYRAZOLO[3,4-B]PYRIDIN-4-YL)MORPHOLIN-2-YL]METHANAMINE

Experimental

Ralinepag

Ralinepag has been used in trials studying the treatment of Pulmonary Arterial Hypertension.
Investigational

PF-05180999

PF-05180999 is under investigation in clinical trial NCT01530529 (A Study to Assess the Relative Bioavailability of a Modified-Release Formulation of PF-05180999).
Investigational

XL281

XL281 is a novel anticancer compound designed to potently inhibit the RAS/RAF/MEK/ERK signaling pathway. Mutational activation of RAS occurs in about 30 percent of all human tumors, including non-small cell lung, pancreatic, and colon cancer. XL281 is a specific inhibitor of RAF kinases, including the mutant form of B-RAF, which...
Investigational
Matched Description: … mutant form of B-RAF, which is activated in 60 percent of melanomas, 24-44 percent of thyroid cancers, and ... activation of RAS occurs in about 30 percent of all human tumors, including non-small cell lung, pancreatic, and …

Oxaprotiline

Oxaprotiline is a norepinephrine reuptake inhibitor of the tetracyclic antidepressant family that is related to maprotiline. This drug was never marketed. Oxaprotiline is a racemic mixture of the isomers levoprotiline and dextroprotiline. Levoprotiline is the R or levo isomer of oxaprotiline (CGP-12,103-A). Dextroprotiline is the S or dextro isomer of...
Experimental
Matched Description: … Oxaprotiline is a racemic mixture of the isomers levoprotiline and dextroprotiline. ... Both enantiomers have antidepressant effects but levoprotiline also is an antihistamine and dextroprotiline …

2-Phenethyl-2,3-Dihydro-Phthalazine-1,4-Dione

Experimental

5-[(4-Methylphenyl)Sulfanyl]-2,4-Quinazolinediamine

Experimental

2-Amino-4-methylphenol

Experimental

5-[3-(2,5-dimethoxyphenyl)prop-1-yn-1-yl]-6-ethylpyrimidine-2,4-diamine

Experimental

PQ-10

Experimental

5-[[(2R)-2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl]methyl]pyrimidine-2,4-diamine

Experimental

MK-0812

MK0812 has been used in trials studying the treatment of Relapsing-Remitting Multiple Sclerosis.
Investigational

AT1391

AT1391 is a daily insulin skin patch designed to provide continuous basal levels of insulin for patients with diabetes.
Investigational

WL-1002

WL-1002 is developed by Winston Laboratories which is a topical cream formulation of 075% zucapaicin (also known as civamide), for the treatment of pain due to osteoarthritis.
Investigational

Actelion-1

Actelion-1 is a tissue-targeting Endothelin Receptor Antagonist that has been discovered by Actelion Pharmaceuticals.
Investigational

Naronapride

Investigational
Displaying drugs 13626 - 13650 of 14855 in total